Loading clinical trials...
Loading clinical trials...
Clinical Significance of CX3CR1 Adhesion Molecule-expressing Myeloid and Lymphoid Cells in Hematologic Malignancy
Conditions
Locations
1
South Korea
The Catholic University of Korea, St.Vincent's hospital
Suwon, Gyeonggi-do, South Korea
Start Date
August 1, 2016
Primary Completion Date
August 1, 2019
Completion Date
August 1, 2021
Last Updated
October 11, 2017
NCT06179888
NCT06152575
NCT04973605
NCT05006716
NCT05201781
NCT06026319
Lead Sponsor
Saint Vincent's Hospital, Korea
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions